| Literature DB >> 29331079 |
Michal Berkenstadt1,2, Ben Pode-Shakked1,3,4,2, Ortal Barel5, Hila Barash1,3, Reuven Achiron6,2, Yinon Gilboa6,2, Dvora Kidron7,2, Annick Raas-Rothschild1,3,2.
Abstract
To describe the prenatal presentation, including ultrasonographic, histologic, and molecular findings, in 2 fetuses affected with LMOD3-related nemaline myopathy. Prenatal ultrasonographic examinations and histopathologic studies were performed on 2 fetuses with evidence of nemaline myopathy. To establish a molecular diagnosis, whole-exome sequencing was pursued for the affected fetuses. Nemaline myopathy is a common form of congenital myopathy manifesting with nonprogressive generalized muscle weakness, hypotonia, and electron-dense protein inclusions in skeletal myofibers. Although clinically, nemaline myopathy can be viewed as a common pathway phenotype, its molecular basis is heterogeneous, with mutations in 11 identified genes implicated in its pathogenesis so far. Whole-exome sequencing revealed that the affected fetuses were compound heterozygous for 2 newly reported pathogenic variants in the LMOD3 gene, which encodes leiomodin 3. To our knowledge, this article is the first report of LMOD3-related nemaline myopathy since the original reported cohort. We provide a detailed description of the prenatal imaging of these affected fetuses, which we hope, in combination with next-generation sequencing, may contribute to further diagnosis in additional families.Entities:
Keywords: LMOD3; arthrogryposis; genetics; leiomodin 3; nemaline myopathy; pediatrics
Mesh:
Substances:
Year: 2018 PMID: 29331079 DOI: 10.1002/jum.14520
Source DB: PubMed Journal: J Ultrasound Med ISSN: 0278-4297 Impact factor: 2.153